Aethoxysklerol® 1% – Polidocanol Injection

Aethoxysklerol® 1% – Polidocanol Injection | European-Made Sclerosing Agent for Global Medical Supply

Product Overview

Aethoxysklerol® (polidocanol injection) is a high-purity sclerosing agent widely used for the treatment of varicose veins, spider veins, and hemorrhoids. It is manufactured in Germany by Kreussler Pharma, a globally recognized pharmaceutical company specializing in vascular and dermatological therapeutics.

This version of Aethoxysklerol® contains 1% polidocanol (10 mg/mL), formulated for intravenous or intralesional use by trained healthcare professionals. It is part of the manufacturer’s global distribution supply, and is identical in composition to versions approved by the EMA and other international health authorities. Packaging and labeling may vary based on regional regulatory requirements.

---

Key Features & Advantages

• ✅ European-Made by Kreussler Pharma (Germany)
  Trusted manufacturer with decades of experience in sclerotherapy solutions.

• ✅ Standardized 1% Polidocanol Formulation
  Ideal for treating telangiectasias and small varicose veins (CEAP C1–C2 classification).

• ✅ Clinically Proven Sclerosing Effect
  Causes endothelial damage and vein closure with minimal patient discomfort.

• ✅ Favorable Safety Profile
  Low risk of hyperpigmentation, matting, or allergic reaction when administered properly.

• ✅ Global Compatibility
  Widely used in Europe, Asia, and South America; suitable for export and institutional purchase.

---

Product Specifications

• Product Name: Aethoxysklerol® 1%

• Active Ingredient: Polidocanol (lauromacrogol 400)

• Concentration: 10 mg/mL (1%)

• Form: Injectable solution

• Presentation: 2 mL or 5 mL ampoules / vials (depending on market)

• Route of Administration: Intravenous (IV) / Intralesional

• Manufacturer: Kreussler Pharma (Germany)

• Packaging: Global/Export version with destination-specific labeling

• Storage: Store below 25°C; protect from light

• Shelf Life: Typically 36 months from manufacture

• Classification: Original brand; not generic

---

Mechanism of Action

Polidocanol acts as a surface-active agent that induces controlled endothelial damage upon direct contact with the vein wall. This leads to platelet aggregation, localized inflammation, and eventual fibrotic closure of the treated vessel.

Aethoxysklerol® 1% is best suited for:

• Reticular veins

• Spider veins (telangiectasias)

• Early-stage varicose veins

• Hemorrhoidal therapy (off-label in some markets)

The 1% concentration provides an effective balance between therapeutic action and patient tolerability, especially in cosmetic sclerotherapy settings.

Reference: PubMed Polidocanol Clinical Review

---

Compliance Statement

This product is manufactured in Germany by Kreussler Pharma and supplied globally under international pharmaceutical trade standards. The formulation is identical to the EU-approved Aethoxysklerol®. Only the packaging and labeling may vary based on the destination country’s regulatory requirements. It is intended for administration by licensed medical professionals only. All importers and users are responsible for ensuring compliance with local healthcare regulations and licensing.

---

Tags / Keywords

Aethoxysklerol 1%, Polidocanol Injection, Sclerotherapy Agent, Varicose Vein Treatment, German-Made Sclerosant, Kreussler Pharma, Spider Vein Removal, Hemorrhoid Sclerotherapy, Cosmetic Phlebology, Vascular Injection Therapy